Aripiprazole augmentation for obsessive-compulsive symptoms of major depressive disorder
- Conditions
- Mental and behavioural disorders
- Registration Number
- KCT0009595
- Lead Sponsor
- Chung-Ang Univerisity Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 60
? Age between 20 and 65 years old
? No prior history of antipsychotic use
? Y-BOCS scale score of 14 or higher, indicating moderate to severe obsessive-compulsive symptoms
? Have been taking a stable dose of antidepressant medication for at least 1 month
? Past or present diagnosis of any other psychiatric condition by SCID-5-CV
? Past or present serious internal medical conditions
? Those with a past or present history of substance dependence or abuse
? Those with a history of epilepsy, head trauma, or temperamental psychiatric disorders
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method